Medical Specimen Tracking System Market Estimated At USD 1.77 Billion By 2030


 San Francisco, 23 March 2022: The Report Medical Specimen Tracking System Market Size, Share & Trends Analysis Report By Product (Software, Consumables), By Technology (Barcode, RFID), By Type, By End User, By Region, And Segment Forecasts, 2022 - 2030

The global medical specimen tracking system market size is anticipated to reach USD 1.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a lucrative CAGR of 10.3% from 2022 to 2030. The key factors driving the market growth include the technological advancements by market players and increasing product adoption for reducing errors in patient diagnosis. Before the COVID-19 pandemic, the adoption of specimen tracking solutions was less. However, due to the pandemic, the demand for these systems skyrocketed, which positively influenced the market growth. Most market players, such as Labcorp Drug Development, Agilent Technologies, and Thermo Fisher Scientific, experienced positive growth from 2019 to 2020 in their segment-specific revenues as well as annual revenues.

For instance, Labcorp Drug Development experienced 21% growth and Thermo Fisher Scientific experienced 26.1% growth from 2019 to 2020. On the other hand, Zebra Technologies Corp. experienced a decline of 3.6% in its Asset, Intelligence, & Tracking segment’s revenue and a 0.8% decline in its annual revenue from 2019 to 2020. Therefore, the overall market was not negatively impacted due to the pandemic. Using barcoding and tracking systems for specimen testing decreases the incidence of errors. According to GA International, the adoption of a medical specimen tracking system reduced the number of errors from 11 to 14 slides out of 10,000 to 0-1 out of 10,000 in the Department of Pathology, University Hospitals Case Medical Center, Cleveland, Ohio.

The study also demonstrated that a 62% reduction in case misidentification was reported in Henry Ford Hospital, Detroit, Michigan, U.S. These factors are anticipated to increase the product adoption, thereby boosting the market growth. Many companies specializing in medical specimen tracking systems hold a significant share of the market. Key players are involved in increasing their market share through R&D, product launches, geographical expansions, partnerships, and other strategies. For example, in November 2020, TrakCel completed the proof-of-concept phase for its technology integration with U.K. NHS partners. The project is part of the development of the MW-ATTC initiative and is funded by the U.K.’s public innovation agency to facilitate the integration of orchestration software into pan-national healthcare IT systems.

Access Research Report of Medical Specimen Tracking System Market @ https://www.grandviewresearch.com/industry-analysis/medical-specimen-tracking-system-market-report

Medical Specimen Tracking System Market Report Highlights

  • On the basis of product, the software segment dominated the market in 2021 due to the increased number of market players dealing in a specimen tracking software
  • The patient testing type segment accounted for the maximum revenue share of the global market in 2021
  • This growth was attributed to the increased product adoption for patient testing purposes
  • Rising technological advancements contributed to the dominant share of the barcode segment in 2021, within the technology segment
  • The pathology laboratories end-user segment is estimated to record the fastest growth rate from 2022 to 2030
  • This growth can be credited to the growing automation of pathology laboratories and rising product adoption in these labs

List of Key Players of the Medical Specimen Tracking System Market

  • RMS Omega Technologies
  • Vision ID
  • GAO RFID Inc.
  • TrakCel
  • Quick International Courier
  • Cryoport Systems, LLC
  • LabConnect
  • Taylor Data Systems, Inc.
  • BioIT Solutions
  • Brooks Automation, Inc.

Access Press Release of Medical Specimen Tracking System Market @ https://www.grandviewresearch.com/press-release/global-medical-specimen-tracking-system-market

 

Comments

Post a Comment

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more

Latin America Nutrition & Dietary Supplements Market Expected To Grow At A CAGR 8.8% For The Forecast Period From 2017 To 2025 : Grand View Research Inc.

San Francisco, 20 May 2019:  The Report  Latin America Nutrition & Dietary Supplements Market  Size, Share & Trends Analysis Report By Formulation, By Function (Medical Foods, Sports Nutrition), By Consumer, By Country, And Segment Forecasts, 2018 – 2025 The Latin America Nutrition & Dietary Supplements Market size is expected to reach USD 47.5 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.8% over the forecast period. Growing expenditure on nutrition and dietary supplements, disposable income, and consumer awareness are some of the key market drivers. Changing regulatory framework to ensure drug safety in Latin American countries such as Mexico and Argentina is also expected to positively impact market growth in the forthcoming years. Growing demand for nutrition and dietary supplements among geriatric population is also one of the considerable market drivers. Nutrition plays a vital role in maintain
Read more

Biomaterials Market Size Poised To Reach USD 348.4 Billion By 2027

Image
  San Francisco, 15 Dec 2020:   The Report  Biomaterials Market  Size, Share & Trends Analysis Report By Product (Natural, Metallic, Polymer), By Application (Cardiovascular, Orthopedics, Plastic Surgery), By Region, And Segment Forecasts, 2020 - 2027 The global biomaterials market size is expected to reach USD 348.4 billion by 2027, registering a CAGR of 15.9% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems. Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The adve
Read more